Company / Interest Expense
Ginkgo Bioworks Holdings, Inc. Interest Expense History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$93.0K
FY2023
5-year range
$93.0K / $2.4M
FY2019-FY2023
Trend
-12.3%
vs FY2022
Sector context
#37 of 42
Health Care
What the data says
Ginkgo Bioworks Holdings, Inc.'s interest expense of $93,000 is lower than 88% of companies in the Health Care sector (FY2023). Interest Expense has declined for 4 consecutive years, from $2M in FY2019 to $93,000 in FY2023.
Based on SEC 10-K filings.
$93,000 in FY2023 with a 3-year CAGR of -66.1%.
Improved from $2M to $93,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -66.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 42This company $93.0K Sector average $305.3M
▼
-100.0% below sector average
Key checks
Key Insights
- Ginkgo Bioworks Holdings, Inc.'s interest expense has declined for 4 consecutive years.
- 3-year CAGR of -66.1%, indicating a declining trend.
- In FY2023, interest expense decreased 12.3% year-over-year.
- Ranks #37 out of 42 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $93.0K | -12.3% |
| FY2022 | $106.0K | -95.5% |
| FY2021 | $2.4M | -0.5% |
| FY2020 | $2.4M | -1.5% |
| FY2019 | $2.4M | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026